权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

A broadly protective subunit vaccine against enterotoxigenic Escherichia coli (ETEC) associateddiarrhea

一种针对产肠毒素大肠杆菌 (ETEC) 相关腹泻的广泛保护性亚单位疫苗

基本信息

批准号：
9912501
负责人：
WEIPING ZHANG
金额：
$ 43.66万
依托单位：
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-05-26 至 2021-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9912501
关键词：
Adult Animal Model Antibodies Antigens Antitoxins Bacteria Bacterial Adhesins Bacterial Attachment Site Bangladesh Cause of Death Cessation of life Child Data Developing Countries Development Diarrhea Disease Dose Enterotoxins Escherichia coli Adhesins Escherichia coli Vaccines Family suidae Genes Genetic Goals Heterogeneity Homeostasis Human Human Volunteers Immunity Immunize Immunologics International Intestines Kansas Laboratories Liquid substance Mediating Methods Modeling Morbidity - disease rate Oryctolagus cuniculus Outcome Prevention Preventive Preventive measure Production Proteins Public Health Recombinant Proteins Recombinants Research Sanitation Small Intestines Subunit Vaccines Toxic effect Toxin Toxoids Traveler&apos s diarrhea Universities Vaccination Vaccines Virulence Virulence Factors Virulent Work diarrheal disease enterotoxigenic Escherichia coli experience global health immunogenicity improved innovation international center mortality neutralizing antibody novel prevent protective efficacy receptor success vaccine candidate vaccine development vaccine efficacy

项目摘要

Project Summary: Diarrhea is the second leading cause of death in children <5 years, and remains a major public health problem. Enterotoxigenic Escherichia coli (ETEC), the most common bacterial cause of diarrhea, causes 280 to 400 million diarrheal cases in children <5 years and 100 million more cases in children >5 years annually, resulting in 150,000 to 300,000 deaths annually. ETEC also commonly cause travellers’ diarrhea. While improved sanitation is the eventual solution, vaccination will be the best preventive measure for many decades. Key virulence factors of ETEC are bacterial adhesins and enterotoxins. Adhesins mediate bacterial attachment to host receptors and colonization in small intestines. Enterotoxins, heat-labile toxin (LT) and heat- stable toxin (STa), disrupt intestinal fluid homeostasis to cause fluid hyper-secretion and diarrhea. A vaccine preventing bacteria colonization and neutralizing toxin enterotoxicity could effectively prevent ETEC diarrhea, but until now, a safe and effective ETEC vaccine has not been developed. Developing ETEC vaccines is challenging since the heterogeneous ETEC strains express at least 23 adhesins and 2 distinct toxins. As ETEC strains producing any one or two adhesins and either toxin (LT or STa) cause diarrhea, ideally, an effective ETEC vaccine should protect against all adhesins and both toxins. But protecting against 23 adhesins is not feasible and protecting against 2 toxins is very difficult. Additionally, suitable animal models to unambiguously assess efficacy of ETEC vaccine candidates have been lacking. In this study, we will develop a safe and broadly protective ETEC vaccine. We will apply a multiepitope fusion antigen (MEFA) method to create an adhesin MEFA to induce antibodies against the 7 key adhesins associates with 80% of ETEC diarrhea cases (caused by ETEC strains with known adhesins), and fuse an LT toxoid and a STa toxoid for a safe toxoid fusion to induce antibodies neutralizing both toxins. The adhesin MEFA and the toxoid fusion will be combined (co-administration) or further fused together (as a CFA-toxoid MEFA) to induce broadly protective anti-adhesin and antitoxin antibodies. We will then use a novel piglet and rabbit dual-challenge model to assess efficacy of a subunit vaccine candidate against ETEC diarrhea. Our preliminary studies show LT-STa toxoid fusions, adhesin MEFA and adhesin-toxoid fusion induce antibodies neutralizing both toxins and 7 adhesins and protecting pigs against ETEC diarrhea, and rabbits and pigs are ideal animal models for ETEC vaccine efficacy assessment. A broadly protective subunit ETEC vaccine will benefit millions of children and travelers. The innovative approaches developed in this research can be generally applied to multivalent vaccine development against other diseases.

项目总结：腹泻是5岁以下儿童死亡的第二大原因，并且仍然是一个主要原因